 |
|
Portable CT increases chance of stroke survival and recovery
December 02, 2008CHICAGO - New research has found that the availability of a portable eight-slice computed tomography (CT) scanner in an emergency room can significantly increase the number of stroke victims who receive a potentially life-saving treatment. Results of the study, conducted at North Shore Medical Center (NSMC)-Salem Hospital in Salem, Mass., will be presented today at the annual meeting of the Radiological Society of North America (RSNA).
"The hospital's acquisition of a portable CT scanner facilitated more rapid assessment of acute stroke patients and is anticipated to increase the number of patients to whom thrombolytic therapy can be administered," said the study's lead author, David B. Weinreb, M.D., now a resident physician in the Department of Radiology at Hospital of Saint Raphael in New Haven, Conn.
According to the National Institute of Neurological Disorders and Stroke (NINDS), stroke is the third leading cause of death in the U.S., and more than 700,000 cases of stroke are diagnosed annually. The most common kind of stroke, ischemic stroke, occurs when a blood clot blocks a blood vessel in the brain. Such strokes can be treated with thrombolytic therapy using a drug called tPA that dissolves the blockage. However, the window of opportunity to safely administer the medication is generally considered to be just three hours. Also, it is important to determine that there is no bleeding in the brain before administering tPA. One out of six strokes is caused by bleeding rather than clotting.
"tPA is usually the only shot we have at clot-induced ischemic strokes," Dr. Weinreb said. "But it needs to be administered in a closely monitored situation, because the drug can have extremely adverse effects in those patients whose strokes are instead due to bleeds."
Before a patient receives tPA, a head CT must be performed to ensure there is no bleeding in the brain. NINDS recommends that patients who arrive in the emergency room (ER) with signs of acute stroke undergo CT imaging within 25 minutes.
For the study, Dr. Weinreb and colleagues began using a portable CT scanner to assess stroke patients in the ER of NSMC-Salem Hospital. During the month prior to the acquisition of the portable scanner and for a four-month period following its installation, researchers measured how much time elapsed between a physician order for a head CT and performance of the scan.
The availability of the CT scanner in the hospital's ER reduced the time between the order and exam from 34 minutes to 15 minutes, a reduction of 54 percent. Based on simulation modeling, the researchers estimated that this improvement would increase by 86 percent the number of stroke patients able to be treated with thrombolytic therapy within the three-hour window.
According to Dr. Weinreb, most stroke patients are taken to relatively small community hospitals where access to CT scanning may be limited. When a CT scanner is available, it is not always in proximity to the ER, making transportation of critically ill patients to the radiology department both difficult and time-consuming.
"A portable eight-slice CT can be easily added and used to accurately identify a head bleed in a stroke or trauma patient," Dr. Weinreb said. "This new technology is able to solve a very important problem for a community hospital, where the majority of stroke victims are being treated."
Radiological Society of North America
"tPA is usually the only shot we have at clot-induced ischemic strokes," Dr. Weinreb said. "But it needs to be administered in a closely monitored situation, because the drug can have extremely adverse effects in those patients whose strokes are instead due to bleeds."
Before a patient receives tPA, a head CT must be performed to ensure there is no bleeding in the brain. NINDS recommends that patients who arrive in the emergency room (ER) with signs of acute stroke undergo CT imaging within 25 minutes.
For the study, Dr. Weinreb and colleagues began using a portable CT scanner to assess stroke patients in the ER of NSMC-Salem Hospital. During the month prior to the acquisition of the portable scanner and for a four-month period following its installation, researchers measured how much time elapsed between a physician order for a head CT and performance of the scan.
The availability of the CT scanner in the hospital's ER reduced the time between the order and exam from 34 minutes to 15 minutes, a reduction of 54 percent. Based on simulation modeling, the researchers estimated that this improvement would increase by 86 percent the number of stroke patients able to be treated with thrombolytic therapy within the three-hour window.
According to Dr. Weinreb, most stroke patients are taken to relatively small community hospitals where access to CT scanning may be limited. When a CT scanner is available, it is not always in proximity to the ER, making transportation of critically ill patients to the radiology department both difficult and time-consuming.
"A portable eight-slice CT can be easily added and used to accurately identify a head bleed in a stroke or trauma patient," Dr. Weinreb said. "This new technology is able to solve a very important problem for a community hospital, where the majority of stroke victims are being treated."
Radiological Society of North America
Science News and Science Current Events Tag Cloud
This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size.
Nanotubes Explosives Insulin Resistance Sarcoma Probiotic Thyroid Syphilis Neurons Carbon Monoxide Gravitational Wave Biomolecules Glycemic Index Testicular Cancer Protein Carbon Footprint Endothelial Cells Gene Therapy Rett Syndrome Tooth Decay Synapses DNA damage Mosquito Zinc Snowmelt Reflux Disease
See More: Science News Tags
Thrombolytic Current Events and Thrombolytic News RSSAspirin and similar drugs may be associated with brain microbleeds in older adults
Individuals who take aspirin or other medications that prevent blood clotting by inhibiting the accumulation of platelets appear more likely to have tiny, asymptomatic areas of bleeding in the brain.
Rush University Medical Center Orthopedic Experts Examine Overhead Throwing Injuries
Baseball season is underway. With the pros, college and high school teams taking to the baseball diamonds and Little Leaguers soon to follow, orthopedic specialists at Rush University Medical Center are cautioning players to be aware of and take precautions against throwing injuries.
Patients who wake up with stroke may be candidates for clot-busters
Giving clot-busting drugs to patients who wake up with stroke symptoms appears to be as safe as giving it to those in the recommended three-hour window, according to researchers at The University of Texas Medical School at Houston.
Stroke therapy window might be extended past nine hours for some
Some patients who suffer a stroke as a result of a blockage in an artery in the brain may benefit from a clot-busting drug nine or more hours after the onset of symptoms. The findings are published in the online edition of Radiology.
WVU study demonstrates efficacy of CT perfusion in diagnosis of acute ischemic stroke
A study conducted by a team of stroke experts from West Virginia University Health Sciences Center demonstrates that CT (computed tomography) perfusion imaging - a technology which measures blood flow and is available to most hospitals - may dramatically improve fast and accurate stroke diagnosis, enabling physicians to provide more targeted care and helping avoid potentially life-threatening complications of "clot buster" therapy.
New research could save lives and millions of dollars
The Hunter Medical Research Institute (HMRI) Stroke Research Group has developed a system to fast track stroke treatment which could benefit thousands of Australian stroke patients and save millions of dollars annually.
Treatment window expanded
Patients can still benefit up to 4.5 hours after a stroke if a drug that dis-solves blood clots in the brain is administered. Thus far, three hours had been considered the useful limit for administering thrombolytic drugs.
New blood clot guidelines for pregnant women
New evidence-based guidelines address the prevention and management of thrombosis in key patient populations and reinforce recommendations related to the routine use of preventive therapies.
Avoiding Spleen Removal for Cooley's Anemia Sufferers
Researchers from Weill Cornell Medical College may have discovered the precise role of a gene in one of the world's most common blood disorders, beta-thalassemia, commonly known as Cooley's anemia.
UGA study suggests that lowering blood pressure following stroke may reduce damage
A new University of Georgia study suggests that commonly prescribed drugs used to lower blood pressure may help reduce brain damage when given within 24 hours of a stroke.
More Thrombolytic Current Events and Thrombolytic News Articles
 |
Anticoagulants, Antiplatelets, and Thrombolytics (Methods in Molecular Medicine) by Shaker A. Mousa (Editor) Albany College of Pharmacy, New York. Highlights the latest developments in antithrombotics and provides experimental methods for the discovery of new and improved anticoagulants. Presents relevant in vitro and in vivo models in thrombosis and hemostasis. For researchers and clinicians. DNLM: Anticoagulants--therapeutic use. |
 |
Thrombolytic Therapy for Acute Stroke by Humana Press This extensively revised and expanded second edition incorporates the knowledge gained from the widespread implementation of large rt-PA for acute stroke trials and demonstrates the power of the new technologies now available. The authors have included much new material on stroke-MRI and computed omogaraphy, and updated all chapters describing the background, use, and nuances of thrombolytic therapy. They present everything one needs to know for proper patient selection, the key to successful treatment. Practical how-to chapters guide the reader in treating acute stroke patients, both with and without thrombolytic therapy. New detailed practice cases that simulate making the rounds in a world-class stroke center prepare practitioners to be as ready as possible for their first case. |
 |
Nattokinase - 1000 FU, 60 Vcaps by Club Natural Pharmaceutical Grade Highest Quality Nattokinase. Nattokinase is an enzyme isolated from the vegetable cheese Natto, a typical and popular soybean food in the Japanese diet. Nattokinase has been found to have blood clot dissolving abilities. Isolated, purified and encapsulated nattokinase, is an enzyme derived from a process of fermentation involving boiled soybeans an bacillus natto. Research has shown nattokinase to support the body in breaking up and dissolving the unhealthy coagulation of blood and to enhance fibrinolytic activity. |
 |
Thrombolytic Therapy for Acute Stroke (Current Clinical Neurology) by Patrick D. Lyden (Editor) This extensively revised and expanded second edition incorporates the knowledge gained from the widespread implementation of large rt-PA for acute stroke trials and demonstrates the power of the new technologies now available. The authors have included much new material on stroke-MRI and computed omogaraphy, and updated all chapters describing the background, use, and nuances of thrombolytic therapy. They present everything one needs to know for proper patient selection, the key to successful treatment. Practical how-to chapters guide the reader in treating acute stroke patients, both with and without thrombolytic therapy. New detailed practice cases that simulate making the rounds in a world-class stroke center prepare practitioners to be as ready as possible for their first case. |
|
Thrombolytic Therapy in the Treatment of Mi [VHS] Starring: Health and Sciences Television Network | |
|
Guidelines for thrombolytics need updating.(Cardiovascular Medicine): An article from: Internal Medicine News by Christine Kilgore (Author) This digital document is an article from Internal Medicine News, published by International Medical News Group on January 15, 2005. The length of the article is 864 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Guidelines for thrombolytics need updating.(Cardiovascular Medicine) Author: Christine Kilgore Publication: Internal Medicine News (Magazine/Journal) Date: January 15, 2005 Publisher: International Medical News Group Volume: 38 Issue: 2 Page: 62(1) Distributed by Thomson... | |
 |
Thrombolytic and Antithrombotic Therapy for Stroke by Julian Bogousslavsky (Editor), Werner Hacke (Editor) Thrombolytic therapy for stroke with the introduction of tissue plasminogen activator (t-PA) was a boon to stroke physicians, since it meant that morbidity and mortality could be reduced with the optimal use of t-PA. Drawing on the experience of the editor and his well-respected contributors, Thrombolytic and Antithrombotic Therapy for Stroke offers the reader personal perspectives on the evidence-based use of various thrombolytic and anti-thrombotic agents that are available and that can provide successful outcomes. Up-to-date and thoroughly referenced, this clearly written text is a resource everyone working in the casualty/emergency room will want at their fingertips. |
 |
Imaging & Intervention in Cardiology by Springer The concept of the book is to give clinicians and interventionalists a unique, up to the minute overview of the use of cardiac imaging techniques in combination with modern interventional procedures such as thrombolysis, catheter-based coronary revascularization, valvuloplasty and interventions in congenital heart disease. The book is divided into sections reflecting the types of interventions listed above. Each section contains several chapters describing how each imaging modality can be used before, during or after intervention to improve outcome, select the optimal interventional strategy or to simply foster our understanding of the interaction between disease and interventional therapy. The idea of the book is to select a number of interventions and imaging techniques ... |
|
Tissue Plasminogen Activator in Thrombolytic Therapy by Desire Collen Burton E. Sobel (Author) | |
|
Acute Coronary Care in the Thrombolytic Era by Robert M. Califf (Author), etc. (Author) |
| © 2009 BrightSurf.com |